Soleus Capital Management as of Dec. 31, 2019
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 49 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Grifols S A Sponsored Adr R (GRFS) | 10.2 | $11M | 453k | 23.29 | |
Essa Pharma (EPIX) | 8.7 | $9.0M | 1.6M | 5.50 | |
Wright Medical Group Nv | 6.7 | $6.9M | 227k | 30.48 | |
Iveric Bio | 5.5 | $5.7M | 668k | 8.58 | |
Allergan | 5.2 | $5.4M | 29k | 191.16 | |
Adverum Biotechnologies | 3.8 | $3.9M | 343k | 11.52 | |
Dex (DXCM) | 3.7 | $3.8M | 18k | 218.69 | |
Aeglea Biotherapeutics | 3.4 | $3.5M | 458k | 7.64 | |
Alexion Pharmaceuticals | 3.3 | $3.4M | 31k | 108.15 | |
Misonix | 3.2 | $3.3M | 179k | 18.61 | |
Iradimed (IRMD) | 3.2 | $3.3M | 141k | 23.37 | |
Vericel (VCEL) | 3.1 | $3.2M | 184k | 17.40 | |
Eiger Biopharmaceuticals | 3.0 | $3.1M | 205k | 14.90 | |
Establishment Labs Holdings Ord (ESTA) | 2.5 | $2.6M | 94k | 27.65 | |
Dermira | 2.4 | $2.5M | 165k | 15.16 | |
Axogen (AXGN) | 2.2 | $2.3M | 128k | 17.89 | |
Biogen Idec (BIIB) | 2.1 | $2.2M | 7.5k | 296.67 | |
Humana (HUM) | 2.0 | $2.1M | 5.8k | 366.38 | |
Xenon Pharmaceuticals (XENE) | 2.0 | $2.1M | 162k | 13.11 | |
Blueprint Medicines (BPMC) | 2.0 | $2.1M | 26k | 80.08 | |
Constellation Pharmceticls I | 1.9 | $2.0M | 42k | 47.10 | |
Amicus Therapeutics (FOLD) | 1.8 | $1.8M | 189k | 9.74 | |
Harpoon Therapeutics | 1.8 | $1.8M | 123k | 14.79 | |
Kadmon Hldgs | 1.5 | $1.6M | 350k | 4.53 | |
Crispr Therapeutics (CRSP) | 1.3 | $1.4M | 22k | 60.90 | |
Steris Plc Ord equities (STE) | 1.3 | $1.3M | 8.8k | 152.39 | |
STAAR Surgical Company (STAA) | 1.2 | $1.3M | 36k | 35.17 | |
Zymeworks | 1.0 | $1.0M | 23k | 45.42 | |
Nevro (NVRO) | 0.9 | $969k | 8.2k | 117.51 | |
Zafgen | 0.9 | $892k | 804k | 1.11 | |
Zealand Pharma A/s- | 0.9 | $892k | 27k | 33.18 | |
Icad (ICAD) | 0.7 | $737k | 95k | 7.77 | |
Flexion Therapeutics | 0.7 | $722k | 35k | 20.69 | |
Rafael Hldgs (RFL) | 0.7 | $676k | 38k | 17.82 | |
Inspire Med Sys (INSP) | 0.6 | $668k | 9.0k | 74.16 | |
Arena Pharmaceuticals | 0.5 | $504k | 11k | 45.41 | |
Tandem Diabetes Care (TNDM) | 0.4 | $453k | 7.6k | 59.61 | |
Natera (NTRA) | 0.4 | $437k | 13k | 33.62 | |
Livongo Health | 0.4 | $422k | 17k | 25.02 | |
Esperion Therapeutics (ESPR) | 0.4 | $399k | 6.7k | 59.55 | |
Guardant Health (GH) | 0.4 | $382k | 4.9k | 77.96 | |
Revance Therapeutics (RVNC) | 0.4 | $376k | 23k | 16.21 | |
Arvinas Ord (ARVN) | 0.3 | $357k | 8.7k | 41.03 | |
Ptc Therapeutics I (PTCT) | 0.3 | $326k | 6.8k | 47.94 | |
Dicerna Pharmaceuticals | 0.2 | $235k | 11k | 21.96 | |
Argenx Se (ARGX) | 0.2 | $240k | 1.5k | 160.00 | |
Shockwave Med | 0.2 | $237k | 5.4k | 43.89 | |
Fate Therapeutics (FATE) | 0.2 | $223k | 11k | 19.56 | |
Syndax Pharmaceuticals (SNDX) | 0.2 | $184k | 21k | 8.77 |